REVIVE LAB UAE is the destination for serious peptide research buyers in the United Arab Emirates — and retatrutide is the single most-requested compound by our executive client base in DIFC, Business Bay, Downtown Dubai and Emirates Hills. There is a reason. The Jastreboff 2023 NEJM Phase 2 trial reported up to 24.2% body weight reduction at 48 weeks on 12 mg retatrutide — numbers that no GLP-1 monoagonist has come close to. For a managing partner in Dubai Marina or a fund principal on Al Reem Island, those numbers translate to one thing: a once-weekly injection that does the work while you fly to Singapore.
This is the protocol our research clients across Jumeirah, JBR, Palm Jumeirah, JVC, Mirdif and Al Barsha actually run. Built around travel schedules, side-effect timing and the brutal calendar reality of UAE business. Research use only — but if you are sourcing the peptide anyway, you should know how the smart money is timing it.
Retatrutide is a triple agonist — it hits GLP-1, GIP and the glucagon receptor simultaneously. That third receptor is the difference maker. GLP-1 alone (semaglutide, tirzepatide is dual) suppresses appetite and slows gastric emptying. The glucagon arm in retatrutide adds direct hepatic fat oxidation and a measurable bump in resting energy expenditure. Translation for the time-poor UAE professional: more fat off, faster, with the same single weekly jab.
Compare the major appetite-pathway peptides REVIVE LAB UAE stocks:
| Peptide | Mechanism | Dose Frequency | Reported Phase 2/3 Loss |
|---|---|---|---|
| Retatrutide 5mg / 10mg | Triple agonist (GLP-1 / GIP / glucagon) | Once weekly SC | ~24% at 48 wk (Jastreboff 2023) |
| Tirzepatide (not stocked) | Dual GLP-1 / GIP | Once weekly SC | ~22% at 72 wk |
| Semaglutide (not stocked) | GLP-1 mono | Once weekly SC | ~15% at 68 wk |
| Tesamorelin 5mg / 10mg | GHRH analog (visceral fat) | Daily SC | ~15-18% VAT (Falutz 2007) |
The other two are not in our catalogue. Retatrutide is, in 5 mg and 10 mg vials, HPLC-tested, lyophilised, ready to reconstitute with 3 mL BAC water. Browse REVIVE LAB UAE retatrutide 5 mg and 10 mg vials in stock now.
The under-discussed truth from Jastreboff 2023: nausea, transient appetite loss and mild GI noise peak roughly 24-48 hours after injection during dose-escalation weeks. For a senior partner with a Sunday 8 AM exec meeting in DIFC, that timing matters more than the dose itself.
If your Sunday is also light (e.g. you fly Monday morning), shift the injection to Friday 8-10 PM. This stretches the peak side-effect window across Saturday and Sunday, leaving Monday's flight relatively comfortable. Many of our Business Bay and JBR research clients use this protocol specifically because of the Heathrow / Riyadh / Mumbai redeye pattern.
The Phase 2 trial used a slow titration for a reason — jump too high and the GI side effects will pull you off the protocol inside two weeks. Research clients we supply across the UAE typically mirror Jastreboff's escalation curve:
| Week | Weekly Dose | Notes |
|---|---|---|
| 1-4 | 2 mg | Tolerance phase. Minimal appetite change. Most professionals report only mild fullness. |
| 5-8 | 4 mg | Appetite suppression becomes obvious. First measurable body recomp. |
| 9-12 | 8 mg | Peak fat oxidation phase. This is where the Jastreboff weight-loss curve steepens. |
| 13-24 | 8-12 mg | Maintenance research dose. Many clients stabilise here for 6-12 months. |
A 5 mg vial reconstituted in 3 mL BAC water yields ~1.67 mg per 0.5 mL — convenient for the early weeks. A 10 mg vial reconstituted the same way doubles the concentration for later titration. Buy retatrutide 5mg in Dubai for the first 8 weeks, then step up to the 10 mg vial — most of our repeat buyers in Emirates Hills and Arabian Ranches run exactly this sequence.
Peptides UAE buyers care about two things beyond purity: speed and discretion. REVIVE Peptides UAE runs an in-house cold-chain courier network that other peptides suppliers in Dubai simply do not match.
REVIVE LAB UAE is the UAE-based peptides supplier built specifically for serious research buyers. Every vial — retatrutide 5 mg, retatrutide 10 mg, tesamorelin, GHK-Cu, BPC-157, TB-500, MOTS-c, Semax, NAD+ — ships with an HPLC certificate of analysis. Vials are stored at 2-8°C, dispatched in cold-chain insulated packaging, and delivered by our own UAE courier fleet (not third-party logistics). We hold live inventory in Dubai; nothing is dropshipped from overseas. Same-day Dubai dispatch is the standard, not a promotion. Browse all REVIVE Peptides UAE products to see the full catalogue.
Retatrutide is a fat-loss agent. It does not preserve lean tissue or repair connective injury. Research clients running cuts in Dubai often pair retatrutide with peptides from a complementary axis:
REVIVE LAB UAE — retatrutide 5 mg and 10 mg vials in stock with same-day Dubai cold-chain courier (Marina, JBR, DIFC, Business Bay, Palm Jumeirah, JVC, Downtown) and next-day delivery to Abu Dhabi, Sharjah, Ajman, RAK and Al Ain. Cash on delivery supported.
At weeks 1-4 (2 mg/week), a 5 mg vial covers approximately 2.5 weeks. At weeks 5-8 (4 mg/week), it covers ~1.25 weeks. Most research clients move to the 10 mg vial from week 5 onward for cost efficiency.
Every REVIVE Peptides UAE retatrutide vial is research-use only, lyophilised, HPLC-tested. Not for human consumption. Not medical advice.